Wave Life Sciences Provides Update on Phase 1b/2a PRECISION-HD Trials

Go back to Wave Life Sciences Provides Update on Phase 1b/2a PRECISION-HD Trials
(NASDAQ: WVE) Delayed: 5.41 +0.21 (4.04%)
Previous Close $5.20    52 Week High $38.50 
Open $5.16    52 Week Low $8.95 
Day High $5.42    P/E N/A 
Day Low $5.14    EPS $0.00 
Volume 2,884,323